Triple-Negative Breast Cancer and Predictive Markers of Response to Neoadjuvant Chemotherapy: A Systematic Review

Around 40–50% of all triple-negative breast cancer (TNBC) patients achieve a pathological complete response (pCR) after treatment with neoadjuvant chemotherapy (NAC). The identification of biomarkers predicting the response to NAC could be helpful for personalized treatment. This systematic review p...

Descripción completa

Detalles Bibliográficos
Autores principales: van den Ende, Nadine S., Nguyen, Anh H., Jager, Agnes, Kok, Marleen, Debets, Reno, van Deurzen, Carolien H. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918290/
https://www.ncbi.nlm.nih.gov/pubmed/36769287
http://dx.doi.org/10.3390/ijms24032969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918290/
https://www.ncbi.nlm.nih.gov/pubmed/36769287
http://dx.doi.org/10.3390/ijms24032969

Ejemplares similares